CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+36.58%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.1B
AUM Growth
+$1.1B
(+41%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
14.22%
Top 10 Holdings %
Top 10 Hldgs %
71.51%
Holding
31
New
7
Increased
13
Reduced
4
Closed
4
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$43.1M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$30.8M |
| 3 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$29.9M |
| 4 |
AbbVie
ABBV
|
$28.7M |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$21M |
Top Sells
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$37M |
| 2 |
HealthStream
HSTM
|
$9.46M |
| 3 |
EVDY
Everyday Health, Inc.
EVDY
|
$9.34M |
| 4 |
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
|
$8.37M |
| 5 |
Option Care Health
OPCH
|
$8.23M |
Sector Composition
| 1 | Healthcare | 69.95% |
| 2 | Financials | 0.05% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $123M | 11.18% | 712,186 +52,000 | +8% | +$8.97M |
|
|
AKRX
2
DELISTED
Akorn, Inc.
AKRX
| $92.1M | 8.39% | 1,938,485 +255,000 | +15% | +$12.1M |
|
|
HPTX
3
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $87.3M | 7.95% | 1,901,930 +650,577 | +52% | +$29.9M |
|
|
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
| $85.6M | 7.79% | 2,192,500 +57,300 | +3% | +$2.24M |
|
|
INSY
5
DELISTED
Insys Therapeutics, Inc.
INSY
| $79M | 7.19% | 1,359,247 +105,000 | +8% | +$6.1M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $74.5M | 6.78% | 3,107,710 +556,175 | +22% | +$13.3M |
|
7
ANI Pharmaceuticals
ANIP
$2.03B
| $70.3M | 6.41% | 1,124,667 +34,600 | +3% | +$2.16M |
|
|
8
AbbVie
ABBV
$372B
| $69M | 6.28% | 1,177,900 +490,000 | +71% | +$28.7M |
|
9
Orthofix Medical
OFIX
$592M
| $56.7M | 5.16% | 1,580,218 +143,723 | +10% | +$5.16M |
|
|
ANAC
10
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $48M | 4.37% | 830,151 -639,539 | -44% | -$37M |
|
11
Enanta Pharmaceuticals
ENTA
$180M
| $47.6M | 4.33% | 1,552,962 -143,185 | -8% | -$4.38M |
|
|
12
Supernus Pharmaceuticals
SUPN
$2.53B
| $43.1M | 3.93% | +3,566,923 | New | +$43.1M |
|
|
PTX
13
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $34.9M | 3.17% | 3,261,484 -166,305 | -5% | -$1.78M |
|
|
TVTY
14
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $33.8M | 3.08% | 1,716,307 +399,814 | +30% | +$7.88M |
|
|
EGRX
15
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $30.8M | 2.81% | +735,922 | New | +$30.8M |
|
|
OSIR
16
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $21.1M | 1.92% | 1,198,336 -476,225 | -28% | -$8.37M |
|
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| $21M | 1.91% | +4,849,870 | New | +$21M |
|
|
DSCI
18
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $13.8M | 1.26% | 1,632,627 | – | – |
|
|
EPRS
19
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $13.6M | 1.24% | +1,523,773 | New | +$13.6M |
|
20
Pacific Biosciences
PACB
$393M
| $11.7M | 1.07% | +2,002,971 | New | +$11.7M |
|
21
Protalix BioTherapeutics
PLX
$124M
| $10M | 0.91% | 5,643,750 +566,412 | +11% | +$1.01M |
|
22
ADMA Biologics
ADMA
$4.12B
| $9.67M | 0.88% | 986,507 +109,100 | +12% | +$1.07M |
|
23
Vericel Corp
VCEL
$1.83B
| $8.71M | 0.79% | 2,352,940 | – | – |
|
24
Lineage Cell Therapeutics
LCTX
$267M
| $7.97M | 0.73% | 1,602,550 | – | – |
|
|
MSLI
25
DELISTED
Merus Labs International Inc.
MSLI
| $2.87M | 0.26% | 1,368,614 +8,400 | +0.6% | +$17.6K |
|